David A. Ricks, SVP and President, Lilly Bio-Meds at LILLY ELI & CO (LLY), sold 3,147 shares at $69.99 ($220K) on 2015-02-04, disclosed to the SEC on 2015-02-06.
Scheduled sale ($220k) by SVP and President, Lilly Bio-Meds under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ADBE | BUY | 2025-01-30 | $999K | — | Filing → |
| ADBE | BUY | 2022-09-27 | $337K | — | Filing → |
| LLY | BUY | 2019-10-25 | $1.0M | — | Filing → |